Our Firm continues to hear from women who allege harm caused by transvaginal mesh marketed by the Johnson & Johnson, subsidiary, Ethicon and several other manufacturers.
New York, NY (PRWEB) January 04, 2015
Nearly 7,400 transvaginal mesh lawsuits (http://www.filevaginalmeshlawsuit.com/) are now pending in the consolidated litigation involving implants from Johnson & Johnson’s Ethicon unit, Bernstein Liebhard LLP reports.
According to court documents dated December 29th, 2014, a total of 7,396 claims are now pending in Bergen County Superior Court, where a state proceeding involving Ethicon’s line of Gynecare implants is underway. Claims filed in the New Jersey litigation similarly accuse the manufacturer of various transvaginal mesh devices of failing to adequately warn about mesh erosion, chronic pain and other complications that may stem from their use. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10)
“Our Firm continues to hear from women who allege harm caused by transvaginal mesh marketed by the Johnson & Johnson, subsidiary, Ethicon and several other manufacturers. We look forward to further progress in this litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices including transvaginal mesh. The Firm is actively filing lawsuits on behalf of women who allegedly sustained complications resulting from products manufactured by Ethicon, C.R. Bard Inc., American Medical Systems Inc. and Boston Scientific Corp.
Transvaginal Mesh Lawsuits
According to court documents, all the transvaginal mesh lawsuits now pending in New Jersey’s Ethicon mesh litigation follow a 2008 alert from the U.S. Food and Drug Administration (FDA) that use of the devices may result in various complications, but that the potential for which was “rare.” In July 2011, the federal agency revised its stance after receiving 3,000 adverse event reports over a three-year period from women who received mesh implants. The risk for vaginal mesh problems was re-categorized at this time as “not rare.” Following these public health alerts, the FDA proposed new regulations in April 2014 that would classify transvaginal mesh devices as high-risk, which would require manufacturers to submit them for rigorous safety testing prior to receiving U.S. market clearance.
Jeffrey S. Grand, a partner at Bernstein Liebhard LLP, is serving as Co-Liaison Counsel in New Jersey’s Ethicon mesh litigation, for which he served on the Plaintiff’s trial team in a proceeding that concluded in March 2013 with a $11 million damage award to a woman whose injuries were found to be a result of the Gynecare Prolift implant she received.
Mr. Grand is also serving as Co-Liaison counsel in a separate proceeding underway in Bergen County established for cases against the device manufacturer, C.R. Bard Inc., and is serving on the Plaintiffs’ Steering Committee for seven separate federal litigations established in West Virginia federal court. These proceedings are now underway in the U.S. District Court, Southern District of West Virginia and include: In Re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation - MDL No. 2187; In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation - MDL No. 2327; Coloplast Corp. Pelvic Support Systems Products Liability Litigation - MDL No. 2387; In Re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation - MDL No. 2440; and In Re: Neomedic Pelvic Repair System Products Liability Litigation - MDL No. 2511.
Women who were allegedly injured by transvaginal mesh may be entitled to compensation for out-of-pocket medical expenses, lost wages, pain and suffering and other injury-related damages. To learn more about filing a transvaginal mesh lawsuit, visit Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP